Eton Pharmaceuticals, Inc. ETON Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s operating lease liabilities (total)?
- Eton Pharmaceuticals, Inc. (ETON) reported operating lease liabilities (total) of $515K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s operating lease liabilities (total) changed year-over-year?
- Eton Pharmaceuticals, Inc.'s operating lease liabilities (total) increased by 214.0% year-over-year, from $164K to $515K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s operating lease liabilities (total)?
- Over 4 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s operating lease liabilities (total) has grown at a 28.1% compound annual growth rate (CAGR), from $195K to $525K.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.